In parallel, CCL2 activities via CCR2, as well as CCL5-induced signaling were demonstrated to contribute to increased EMT and twist expression, at times accompanied by increased tumor cell invasion in breast cancer cells (93–96). This evidence concerns the gene CCR2 and breast carcinoma.